tiprankstipranks
Advertisement
Advertisement

Mitsubishi Chemical Group Profits Rise Despite Lower Revenue After Portfolio Restructuring

Story Highlights
  • Mitsubishi Chemical Group’s nine-month revenue fell, but net income and EPS rose sharply.
  • The company maintains dividend plans while forecasting lower sales and mixed profit trends amid restructuring.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mitsubishi Chemical Group Profits Rise Despite Lower Revenue After Portfolio Restructuring

Claim 55% Off TipRanks

Mitsubishi Chemical Holdings ( (JP:4188) ) has shared an announcement.

For the nine months to 31 December 2025, Mitsubishi Chemical Group reported an 8.2% year-on-year decline in sales revenue to ¥2.74 trillion from continuing operations, while core operating income slipped 2.4% to ¥185.6 billion and operating income fell 22.2%. Despite lower revenue and operating profit, net income attributable to owners of the parent surged 77.6% to ¥105.4 billion and basic earnings per share rose to ¥76.70, supported partly by portfolio changes and the classification of its former pharmaceuticals business as discontinued operations; equity attributable to owners also increased, lifting the equity ratio to 31.8%. The company kept its full-year dividend forecast unchanged at ¥32 per share and revised its fiscal 2025 earnings outlook, projecting a 7.0% drop in annual sales revenue but higher core operating income, alongside a sharp fall in operating income and income before taxes, underscoring ongoing restructuring effects and margin pressures even as profitability to shareholders improves.

The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1151.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.

More about Mitsubishi Chemical Holdings

Mitsubishi Chemical Group Corporation is a diversified Japanese chemical manufacturer listed on the Tokyo Stock Exchange, operating under IFRS and active across multiple materials and chemical segments. The group recently restructured its portfolio by transferring former pharmaceutical subsidiary Mitsubishi Tanabe Pharma Corporation (now Tanabe Pharma Corporation) and related entities, reflecting a sharper focus on its core chemical and materials businesses while maintaining a global footprint that includes newly consolidated entities such as Australian gas supplier Coregas Pty Ltd.

Average Trading Volume: 5,129,671

Technical Sentiment Signal: Buy

Current Market Cap: Yen1438.4B

For an in-depth examination of 4188 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1